What’s Next for Biopharma? Tevogen’s (TVGN) AI Breakthrough at the J.P. Morgan Conference - InvestingChannel

What’s Next for Biopharma? Tevogen’s (TVGN) AI Breakthrough at the J.P. Morgan Conference

We recently compiled a list of the 13 AI News Investors Should Not Miss. In this article, we are going to take a look at where Tevogen Bio Holdings Inc. (NASDAQ:TVGN) stands against the other AI news investors should not miss.

As we look toward 2025, the AI investment landscape is evolving from a focus on general-purpose computing to custom-built solutions tailored to specific needs. This shift opens up opportunities for suppliers of specialized technology and software companies to incorporate AI into their offerings. Meanwhile, higher interest rates may push investors toward established players with strong growth potential in the AI space.

READ ALSO: 12 AI News and Ratings Investors Are Watching Right Now and Jim Cramer’s Latest Lightning Round: 8 Stocks in Focus.

Custom Silicon and AI Drive Market Shifts in 2025

At CNBC’s ‘Closing Bell,’ Doug Clinton of Intelligent Alpha and Deepwater Asset Management discussed the shifting dynamics of AI investments heading into 2025. He explained that while Nvidia has been a key beneficiary of AI-driven spending over the past two years, with companies investing heavily in general-purpose AI compute, the focus is now transitioning to custom silicon. Companies like Google, Microsoft, Meta, and Amazon have developed their own custom chips designed to handle their specific AI needs. Clinton believes that as these companies begin to deploy their custom chips more aggressively, suppliers like Broadcom, which works with most of these tech giants, and Marvell, another stock in Intelligent Alpha’s portfolio, could see growth.

He compared the current AI trend to the dot-com era, where Cisco was a dominant player. He stressed that the AI market is not solely about one company, and as the sector evolves, more companies will emerge as key players, broadening the scope of AI investments.

Regarding the impact of interest rates, Clinton noted that higher rates might push investors back to mega-cap stocks, but also highlighted that companies with strong AI growth potential, like Snowflake, could still thrive. The company has been expanding its AI offerings and could attract attention as more customers deploy its services for AI applications.

For this article, we selected AI stocks by going through news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey’s database of 900 hedge funds.

Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 275% since May 2014, beating its benchmark by 150 percentage points (see more details here).

Tevogen Bio Holdings Inc. (NASDAQ:TVGN)

Number of Hedge Fund Holders: 10

Tevogen Bio Holdings Inc. (NASDAQ:TVGN) is a clinical-stage company specializing in immunotherapy, creating targeted T-cell treatments to meet unaddressed medical needs. The company owns a portfolio of patents and applications related to AI, developed without relying on third-party licenses.

Tevogen Bio (NASDAQ:TVGN) announced it will host an AI-focused panel at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco. Titled “AI in Biopharma: Next Frontier of Medical Innovation,” the panel will feature experts from Tevogen.AI, Microsoft, and Rubix Health, discussing AI’s role in transforming biopharma. Topics will include advancements in drug discovery, faster development, improved patient access, and cost efficiency, with a focus on Tevogen’s AI-driven efforts to improve precision T-cell therapies.

Overall, TVGN ranks 8th on our list of AI news investors should not miss. While we acknowledge the potential of TVGN as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TVGN but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 8 Best Wide Moat Stocks to Buy Now and 30 Most Important AI Stocks According to BlackRock.

Disclosure: None. This article is originally published at Insider Monkey.

Related posts

Advisors in Focus- January 6, 2021

Gavin Maguire

Advisors in Focus- February 15, 2021

Gavin Maguire

Advisors in Focus- February 22, 2021

Gavin Maguire

Advisors in Focus- February 28, 2021

Gavin Maguire

Advisors in Focus- March 18, 2021

Gavin Maguire

Advisors in Focus- March 21, 2021

Gavin Maguire